Literature DB >> 34762551

TIPICO XI: report of the first series and podcast on infectious diseases and vaccines (aTIPICO).

Federico Martinón-Torres1, Adolfo García-Sastre2,3,4,5, Andrew J Pollard6, Carlos Martín7, Albert Osterhaus8, Shamez N Ladhani9, Octavio Ramilo10, Jose Gómez Rial11, Antonio Salas12, F Xavier Bosch13, María Martinón-Torres14, Michael J Mina15, James Cherry16.   

Abstract

TIPiCO is an annual expert meeting and workshop on infectious diseases and vaccination. The edition of 2020 changed its name and format to aTIPiCO, the first series and podcasts on infectious diseases and vaccines. A total of 13 prestigious experts from different countries participated in this edition launched on the 26 November 2020. The state of the art of coronavirus disease-2019 (COVID-19) and the responsible pathogen, the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), and the options to tackle the pandemic situation were discussed in light of the knowledge in November 2020. Despite COVID-19, the status of other infectious diseases, including influenza infections, respiratory syncytial virus disease, human papillomavirus infection, measles, pertussis, tuberculosis, meningococcal disease, and pneumococcal disease, were also addressed. The essential lessons that can be learned from these diseases and their vaccines to use in the COVID-19 pandemic were also commented with the experts.

Entities:  

Keywords:  COVID-19 pandemic; Infectious disease; control of transmission; severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2); vaccine-immunity response; vaccine-preventable disease

Mesh:

Substances:

Year:  2021        PMID: 34762551      PMCID: PMC8828069          DOI: 10.1080/21645515.2021.1953351

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  101 in total

Review 1.  Mechanisms of BCG in the treatment of bladder cancer-current understanding and the prospect.

Authors:  Jiansong Han; Xinquan Gu; Yang Li; Qiaoli Wu
Journal:  Biomed Pharmacother       Date:  2020-06-16       Impact factor: 6.529

2.  'Pertussis vaccine encephalopathy': it is time to recognize it as the myth that it is.

Authors:  J D Cherry
Journal:  JAMA       Date:  1990 Mar 23-30       Impact factor: 56.272

3.  Virology, transmission, and pathogenesis of SARS-CoV-2.

Authors:  Muge Cevik; Krutika Kuppalli; Jason Kindrachuk; Malik Peiris
Journal:  BMJ       Date:  2020-10-23

Review 4.  Twentieth anniversary of Homo antecessor (1997-2017): a review.

Authors:  José María Bermúdez de Castro; María Martinón-Torres; Juan Luis Arsuaga; Eudald Carbonell
Journal:  Evol Anthropol       Date:  2017-07

5.  Preventive Strategies for Respiratory Syncytial Virus Infection in Young Infants.

Authors:  Jeanette Taveras; Octavio Ramilo; Asuncion Mejias
Journal:  Neoreviews       Date:  2020-08

6.  HPV vaccination: Are we overlooking additional opportunities to control HPV infection and transmission?

Authors:  Alex Vorsters; Pierre Van Damme; F Xavier Bosch
Journal:  Int J Infect Dis       Date:  2019-09-12       Impact factor: 3.623

7.  Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as a live virus vaccine candidate.

Authors:  Weina Sun; Sarah R Leist; Stephen McCroskery; Yonghong Liu; Stefan Slamanig; Justine Oliva; Fatima Amanat; Alexandra Schäfer; Kenneth H Dinnon; Adolfo García-Sastre; Florian Krammer; Ralph S Baric; Peter Palese
Journal:  EBioMedicine       Date:  2020-11-21       Impact factor: 8.143

8.  Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.

Authors:  Merryn Voysey; Sue Ann Costa Clemens; Shabir A Madhi; Lily Y Weckx; Pedro M Folegatti; Parvinder K Aley; Brian Angus; Vicky L Baillie; Shaun L Barnabas; Qasim E Bhorat; Sagida Bibi; Carmen Briner; Paola Cicconi; Andrea M Collins; Rachel Colin-Jones; Clare L Cutland; Thomas C Darton; Keertan Dheda; Christopher J A Duncan; Katherine R W Emary; Katie J Ewer; Lee Fairlie; Saul N Faust; Shuo Feng; Daniela M Ferreira; Adam Finn; Anna L Goodman; Catherine M Green; Christopher A Green; Paul T Heath; Catherine Hill; Helen Hill; Ian Hirsch; Susanne H C Hodgson; Alane Izu; Susan Jackson; Daniel Jenkin; Carina C D Joe; Simon Kerridge; Anthonet Koen; Gaurav Kwatra; Rajeka Lazarus; Alison M Lawrie; Alice Lelliott; Vincenzo Libri; Patrick J Lillie; Raburn Mallory; Ana V A Mendes; Eveline P Milan; Angela M Minassian; Alastair McGregor; Hazel Morrison; Yama F Mujadidi; Anusha Nana; Peter J O'Reilly; Sherman D Padayachee; Ana Pittella; Emma Plested; Katrina M Pollock; Maheshi N Ramasamy; Sarah Rhead; Alexandre V Schwarzbold; Nisha Singh; Andrew Smith; Rinn Song; Matthew D Snape; Eduardo Sprinz; Rebecca K Sutherland; Richard Tarrant; Emma C Thomson; M Estée Török; Mark Toshner; David P J Turner; Johan Vekemans; Tonya L Villafana; Marion E E Watson; Christopher J Williams; Alexander D Douglas; Adrian V S Hill; Teresa Lambe; Sarah C Gilbert; Andrew J Pollard
Journal:  Lancet       Date:  2020-12-08       Impact factor: 79.321

9.  Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial.

Authors:  Michele D Tameris; Mark Hatherill; Bernard S Landry; Thomas J Scriba; Margaret Ann Snowden; Stephen Lockhart; Jacqueline E Shea; J Bruce McClain; Gregory D Hussey; Willem A Hanekom; Hassan Mahomed; Helen McShane
Journal:  Lancet       Date:  2013-03-23       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.